About

About US

TruLab was started by technology and medical professionals for pharmaceutical developers.

 

We know how to use the technology of tomorrow to solve the problems of today. You know how to create, develop, and test life-saving pharmaceuticals.  Let’s work together.

01. World Leader in Biological Sample Tracking

Our mission is to be the world leader in biological sample tracking, advancing research and development of new medical therapies.

We do it by replacing sharpies on tubes and burdensome paper processes.

We may not be developing life-saving drugs but we’re empowering the companies that are.

02. We design with the end-user in mind

We understand that front-line workers are not the ones making purchase decisions for sample-tracking software.

But we also understand that software is only valuable if end-users want to use it.

At TruLab, we aim to develop sample tracking solutions with user experience that clinical site technicians will love and results that high-level executives will love.

 

03. trulab employees enjoy coming into work

We work hard. We have fun doing it.

We think those two sentences complement each other well, not take away from each other. Every meeting should feature laughs, smiles, and people enjoying being at work.

TruLab

A Team Of Professionals

Scott Ogle

Scott Ogle

Chief Executive Officer

Scott is an experienced business leader who has been humbled by the challenges and tests of resiliency from starting and growing businesses. Most recently, he was CEO of Sageworks ...Read More

Scott Ogle

Chief Executive Officer
Scott Ogle

Scott Ogle

Chief Executive Officer

Scott is an experienced business leader who has been humbled by the challenges and tests of resiliency from starting and growing businesses. Most recently, he was CEO of Sageworks where he was part of a team that grew the company from a startup to a 300-person, world-class company that was purchased by a leading private equity firm.

Prior to that he had experience building and selling a startup company in Silicon Valley and spent time on Wall Street with Merrill Lynch.

Scott was raised by a father who was a NC public school math teacher and mother who was an artist. He was an Eagle Scout, attended high school at the North Carolina School of Science & Mathematics, and obtained his B.A. in Economics from the University of North Carolina at Chapel Hill.

Scott is also a graduate of the prestigious NC School of Science and Mathematics.

David Chung

David Chung

Chief Operating Officer

David Chung has over 20 years of leadership and business management experience in startups and non-profits.

Most recently, David was a Director at Andromeda Simulations, a corpo...Read More

David Chung

Chief Operating Officer
David Chung

David Chung

Chief Operating Officer

David Chung has over 20 years of leadership and business management experience in startups and non-profits.

Most recently, David was a Director at Andromeda Simulations, a corporate finance training company established in 1996, where he led the turn-around of the sales and marketing operations of the company, transforming it from a referrals-based business to establishing an outbound strategy to produce scalable and predictable revenue.

David was an early employee at Sageworks, a fintech startup that was acquired by Accel-KKR in 2019, and has also spent the past decade serving as an advisor to various technology startups.

Anthony Wang

Anthony Wang

Head of Development

Anthony has over 20 years of experience building technology for startups and growth-stage companies.

He has developed high-performance systems and teams across a wide range of d...Read More

Anthony Wang

Head of Development
Anthony Wang

Anthony Wang

Head of Development

Anthony has over 20 years of experience building technology for startups and growth-stage companies.

He has developed high-performance systems and teams across a wide range of domains, including ecommerce, enterprise software, financial services, and hospitality. Recently, Anthony was co-founder and President at Tobi.com, an online fast fashion retailer, where he was responsible for technology and marketing. There, helped grow the business to over 300 employees with a 120,000 sq ft fulfillment center shipping to over 100 countries worldwide. Previously, Anthony had been an early employee at Xtime (acquired by Cox Automotive) and Scient (IPO).

Anthony holds a B.S. in Electrical Engineering and Computer Science from UC Berkeley. He is also a graduate of Monta Vista High School, a top-50 nationally-ranked high school.

Nicole Wolfgang

Nicole Wolfgang

Chief Compliance Officer

Nicole Wolfgang has 20 years of experience in accounting, finance, management, and compliance in startups and growth-stage businesses.

Before joining TruLab, Nicole led the fina...Read More

Nicole Wolfgang

Chief Compliance Officer
Nicole Wolfgang

Nicole Wolfgang

Chief Compliance Officer

Nicole Wolfgang has 20 years of experience in accounting, finance, management, and compliance in startups and growth-stage businesses.

Before joining TruLab, Nicole led the finance/accounting team at BlueAlly Technology Solutions, an IT infrastructure and technology managed services company. Prior to that, she was an employee at Sageworks from 2004 through its acquisition in 2018, where she served as Vice President of Finance and Corporate Secretary and led due diligence efforts related to its acquisition.

Nicole earned her B.S. with a double major in Economics and Magazine Journalism from Syracuse University. She also holds an M.A. in Economics from Duke University and a M.Acc. from Kenan-Flagler Business School at the University of North Carolina at Chapel Hill.

Hardy Butler

Hardy Butler

Chief Financial Officer

Hardy provides clients with assistance in all aspects of their financial decision-making, management of cash flow, business development, and long-term planning and execution. Hardy...Read More

Hardy Butler

Chief Financial Officer
Hardy Butler

Hardy Butler

Chief Financial Officer

Hardy provides clients with assistance in all aspects of their financial decision-making, management of cash flow, business development, and long-term planning and execution. Hardy holds a B.S. degree in Electrical Engineering, with a second major in Mathematics, from Duke University and an MBA, with a concentration in Finance, from the UNC Kenan-Flagler Business School.

R.J. Sims Preston, JD

R.J. Sims Preston, JD

Board of Advisors

R.J. Sims Preston, JD was the Chairman and President of Polyglot Systems, Inc. from November 2010 to March 2017 when the company was sold to a strategic buyer, s...Read More

R.J. Sims Preston, JD

Board of Advisors
R.J. Sims Preston, JD

R.J. Sims Preston, JD

Board of Advisors

R.J. Sims Preston, JD was the Chairman and President of Polyglot Systems, Inc. from November 2010 to March 2017 when the company was sold to a strategic buyer, securing a substantial return for shareholders.

Prior to joining Polyglot, Sims spent 14 years as a lawyer, both in private practice and as in-house counsel for some of the world’s most dynamic and innovative companies, including Quintiles Transnational Corp. (now IQVIA) and Nuance Communications, Inc.

In addition to his executive experience, Sims’ legal work has involved software licensing, strategic transactions, intellectual property prosecution and maintenance and litigation. Mr. Preston earned a BA from Columbia University and is a cum laude graduate of Duke University School of Law.

Julius M. Wilder MD, PHD

Julius M. Wilder MD, PHD

Board of Advisors

Dr. Julius Wilder obtained the first MD, PhD in Medical Sociology in the history of Duke University. Following medical school and graduate school he completed a residency in intern...Read More

Julius M. Wilder MD, PHD

Board of Advisors
Julius M. Wilder MD, PHD

Julius M. Wilder MD, PHD

Board of Advisors

Dr. Julius Wilder obtained the first MD, PhD in Medical Sociology in the history of Duke University. Following medical school and graduate school he completed a residency in internal medicine at Duke where he served as an Assistant Chief Resident. At the end of his residency, Dr. Wilder completed a fellowship in gastroenterology and an advanced transplant hepatology fellowship at Duke. He is an Assistant Professor of Medicine and has a tenure-track faculty appointment in the Duke School of Medicine, the Duke Clinical Research Institute, and the Duke Department of Sociology (secondary appointment). He serves on the Duke School of Medicine executive admissions committee, Duke School of Medicine institutional review committee, and is the Diversity Chair for the Duke Division of Gastroenterology.

Dr. Wilder has numerous publications and has won awards for his research in hepatology, GI, and on social determinants of health. He is the Principal Investigator (PI) or Co-PI on multiple clinical trials in gastroenterology, hepatology and transplant hepatology. His clinical duties include working as a gastroenterologist/hepatologist at Duke University and Duke Regional Hospitals in Durham, North Carolina.

Karin Jorga, PhD

Karin Jorga, PhD

Board of Advisors

Dr. Karin Jorga, PhD, has over 20 years of experience in drug development of small and large molecules across all therapeutic areas. The focus of her international experience has b...Read More

Karin Jorga, PhD

Board of Advisors
Karin Jorga, PhD

Karin Jorga, PhD

Board of Advisors

Dr. Karin Jorga, PhD, has over 20 years of experience in drug development of small and large molecules across all therapeutic areas. The focus of her international experience has been on transitioning pre-clinical lead molecules to Clinical Proof-of-Concept and advancing novel biomarkers to drive Personalized Healthcare. She has a substantial scientific track record in Clinical Pharmacology and a unique set of expertise that includes the usage of Biomarkers and application of Computer Models to overcome drug development hurdles and drive scientifically sound decision making.

Dr. Jorga’s past experience includes being the Global Head of Biomarker Technology and Science, Global Head of Clinical Pharmacology, and Global Head of Modeling and Simulation at Roche.

She currently runs a consulting firm, KarinJorga Life Science Consulting, that was founded in 2014 in Basel with the ambition to develop scientific innovations into medicines for tomorrow.

Kelly W Padilla, BSPharm PharmD

Kelly W Padilla, BSPharm PharmD

Board of Advisors

Dr. Padilla is a clinical pharmacist of over 20 years who has served in many clinical leadership roles within the pharmaceutical industry: global clinical supplies, regulatory affa...Read More

Kelly W Padilla, BSPharm PharmD

Kelly W Padilla, BSPharm PharmD

Board of Advisors

Dr. Padilla is a clinical pharmacist of over 20 years who has served in many clinical leadership roles within the pharmaceutical industry: global clinical supplies, regulatory affairs regulatory intelligence, medical writing, global medical affairs, medical communications, and hospital pharmacy.

She has been the global medical information lead for several product launches and has been a functional head in several pivotal trials in respiratory, oncology, HIV, CNS, urology, and orthopedics; for both small molecules and biologics. Kelly holds a Doctor of Pharmacy from the University of Florida, and a Bachelor of Science of Pharmacy from the University of North Carolina – Chapel Hill.

Dr. Padilla is also a graduate of the prestigious NC School of Science and Mathematics.

Personal: Outside of work, Kelly plays the flute and dances salsa. She enjoys traveling and cuddling with her 2 daughters and fur-baby Naomi the poodle.

Bimal Shah, MD, MBA

Bimal Shah, MD, MBA

Board of Advisors

Dr. Bimal Shah is currently the Chief Medical Officer at Livongo (NASDAQ: LVGO).

Dr. Shah is responsible for Livongo’s strategic clinical product vision, clinical content, and...Read More

Bimal Shah, MD, MBA

Board of Advisors
Bimal Shah, MD, MBA

Bimal Shah, MD, MBA

Board of Advisors

Dr. Bimal Shah is currently the Chief Medical Officer at Livongo (NASDAQ: LVGO).

Dr. Shah is responsible for Livongo’s strategic clinical product vision, clinical content, and clinical research and analytics. Dr. Shah previously served as the company’s Senior Vice President for Clinical and Strategic Partnerships, where he provided clinical guidance and launched Livongo first cardiovascular product offering, assisted in strategic pursuits, and explored opportunities to expand Livongo’s offerings into other parts of the healthcare market. Prior to Livongo, Dr. Shah was the Service Line Vice President at Premier, Inc for its real-world evidence business.

Prior to Premier, Dr. Shah served as an Assistant Professor at Duke University, where he held numerous leadership positions in research programs and clinical administration. Dr. Shah graduated from the University of North Carolina – Chapel Hill with the highest honors and earned both a Doctor of Medicine and Masters in Business Administration from Duke University. Dr. Shah completed his residency in Internal Medicine at Stanford University before finishing a General Cardiology fellowship at Duke University. He is also a member of both the Board of Advisors for the Duke School of Nursing and Board of Visitors for the University of North Carolina – Chapel Hill. Dr. Shah is a practicing cardiologist.

Dr. Shah is also a graduate of the prestigious NC School of Science and Mathematics.

Richard Graham

Richard Graham

Board of Advisors

Richard A. Graham, Ph.D., was appointed Senior Vice President, Development in August 2020, where he is responsible for leading the progression of late-stage clinical assets through...Read More

Richard Graham

Board of Advisors
Richard Graham

Richard Graham

Board of Advisors

Richard A. Graham, Ph.D., was appointed Senior Vice President, Development in August 2020, where he is responsible for leading the progression of late-stage clinical assets through regulatory filing and approval. Since joining Theravance Biopharma, Dr. Graham has served as Vice President of Clinical Pharmacology, and more recently, as Vice President of Clinical Development.

Prior to joining Theravance Biopharma, Dr. Graham spent five years at GlaxoSmithKline working in the area of Drug Metabolism and Pharmacokinetics, seven years at Genentech/Roche as a clinical pharmacologist and Global Development Team Leader, and one year at Onyx Pharmaceuticals where he headed Translational Medicine. In his nearly 20-year career, he worked across all stages of drug development and all major therapeutic areas.

Dr. Graham received his Bachelor’s and Master’s degree in Biochemistry from Iowa State University and his Doctorate of Philosophy degree in Pharmaceutical Sciences from The University of North Carolina at Chapel Hill.

T rustworthy

R esponsive

U nreasonably Fast

L ove for Customers

A uthentic

B old

some numbers that tell you about us

Stats About Our Team

Combined Years Experience in Phamacology & Medicine

%

Alumni of Blue Blood NCAA Basketball Programs

Eagle Scouts

Languages Spoken By Our Team (And That's Before We Start Counting the Programming Languages)

Combined PHD's, MD's, & PharmD's

Combined Years of Software Development for Business, Medtech, and Event Planning

Get In Touch

9 + 14 =

110 Corcoran Street
5th Floor
Durham, NC 27701
 
 
 
 
 
 
 
 
+1 (919) 972 8475 
 
info@trulab.com